<DOC>
	<DOCNO>NCT00744276</DOCNO>
	<brief_summary>The purpose study determine safety three dos topically apply danazol compare placebo subject pain associate fibrocystic breast disease determine appropriate clinical dose future study .</brief_summary>
	<brief_title>A Study Topical Danazol Treatment Pain Associated With Fibrocystic Breast Disease</brief_title>
	<detailed_description />
	<mesh_term>Breast Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Fibrocystic Breast Disease</mesh_term>
	<mesh_term>Danazol</mesh_term>
	<criteria>Menstruating female least 18 year age Has moderate severe breast pain associated cyclical fibrocystic breast disease Is good general health Pregnant within past 6 month lactate History malignancy currently treat cancer breast genital organ Has take within past 3 month currently take hormonal contraception Has condition androgen steroid contraindicate Has breast implant breast reduction surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>fibrocystic breast disease</keyword>
	<keyword>fibrocystic disease breast</keyword>
	<keyword>breast pain</keyword>
	<keyword>mastalgia</keyword>
	<keyword>cyclic mastalgia</keyword>
	<keyword>cystic breast disease</keyword>
</DOC>